Literature DB >> 17068106

IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells.

Toshio Kitawaki1, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama.   

Abstract

Dendritic cells (DCs) and mast cells (MCs) co-localize in peripheral tissues of antigen entry, i.e. skin and mucosa. Due to the proximity of these two cell types, activation of MCs may affect DC functions. Here, we co-cultured human monocyte-derived DCs with cord blood-derived MCs activated by cross-linking of FcepsilonRI to elucidate the net effect of the whole MC products on DCs. Activated MCs induced maturation of DCs, and potently suppressed IL-12p70 production by the DCs. Whereas co-culture of DCs with activated MCs alone did not significantly influence the type of CD4(+) T cell responses induced by the DCs, DCs co-cultured with activated MCs in the presence of pro-inflammatory or T(h)1-inducing factors caused T(h)2 polarization. Although histamine was involved in the induction of DC maturation and T(h)2 polarization by activated MCs, a combinatorial effect of various MC-derived factors, including those acting in a cell contact-dependent manner, was required for the optimal induction of T(h)2-promoting DCs. Furthermore, we demonstrated that clusters of DCs are located closely with MCs in lesions of atopic dermatitis. Collectively, this study suggests that the interaction between DCs and IgE-activated MCs in a pro-inflammatory or even T(h)1-prone environment is instrumental in maintaining and augmenting T(h)2 responses in allergy, and that disruption of the DC-MC interaction may constitute an effective strategy to treat ongoing allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068106     DOI: 10.1093/intimm/dxl113

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  23 in total

1.  Indirect involvement of allergen-captured mast cells in antigen presentation.

Authors:  Taku Kambayashi; Jan D Baranski; Rebecca G Baker; Tao Zou; Eric J Allenspach; Jonathan E Shoag; Peter L Jones; Gary A Koretzky
Journal:  Blood       Date:  2007-11-21       Impact factor: 22.113

Review 2.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

Review 3.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 4.  IgE receptor signaling in food allergy pathogenesis.

Authors:  Hans C Oettgen; Oliver T Burton
Journal:  Curr Opin Immunol       Date:  2015-09-18       Impact factor: 7.486

Review 5.  Roles of basophils and mast cells in cutaneous inflammation.

Authors:  Atsushi Otsuka; Yumi Nonomura; Kenji Kabashima
Journal:  Semin Immunopathol       Date:  2016-05-11       Impact factor: 9.623

6.  The inflammatory twitch as a general strategy for controlling the host response.

Authors:  Joshua J Pothen; Matthew E Poynter; Jason H T Bates
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

Review 7.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

Review 8.  The roles of the prostaglandin D(2) receptors DP(1) and CRTH2 in promoting allergic responses.

Authors:  R Pettipher
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 9.  Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.

Authors:  Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06       Impact factor: 10.793

10.  Mast cells impair the development of protective anti-tumor immunity.

Authors:  Anna Wasiuk; Dyana K Dalton; William L Schpero; Radu V Stan; Jose R Conejo-Garcia; Randolph J Noelle
Journal:  Cancer Immunol Immunother       Date:  2012-06-10       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.